Catálogo de publicaciones - libros

Palabras clave – provistas por la editorial

patient-derived tumor xenograft (PDX); anti-cancer drug development; immunodeficient mice; precision medicine; molecular profiling; immunohistochemistry; next-generation sequencing; targeted therapy; molecular oncology; biomarkers; molecular imaging; non-small cell lung cancer; proliferation; cancer stem cells; circulating tumour cells; personalised treatment; renal cell carcinoma; clear cell; VEGF; immunotherapy; PD-L1; immune checkpoint inhibitors; immune checkpoint blockade; tyrosine-kinase inhibitors; integrin-linked kinase (ILK); ovarian cancer; sgRNA; gene expression; microarray; xenograft; MTB; cancer; oncology practice; community setting; CGP; pancreatic cancer; FOLFIRINOX; chemotherapy; gender; cholangiocarcinoma; biliary tract cancer; prognosis; neutrophils; BRCA1; BRCA2; PALB2; homologous recombination repair; colorectal cancer; heme oxygenase-1; endothelin-1; endothelin con-verting enzyme-1; bosentan; precision oncology; tumor-agnostic indications; solid tumors; tumor markers; FDA-approved therapeutics; n/a